Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Buckner

Showing results (111-120 of 417) with videos related to

Pageof 42
Sort By:
Cancer Research|October 15, 1989
Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignanciesC M Higuchi, J A Thompson, T Cox, et al.
Archives of Internal Medicine|August 1, 1973
Isogeneic marrow grafts for hematologic malignancy in manR H Rudolph, A Fefer, E D Thomas, et al.
Stem Cells (Dayton, Ohio)|December 1, 1995
Transplantation of allogeneic peripheral blood stem cellsW I Bensinger, F A Appelbaum, T Demirer, et al.
Experimental Hematology|January 1, 1974
Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrowC D Buckner, R A Clift, A Fefer, et al.
Transplantation Proceedings|December 1, 1979
Histocompatibility and marrow transplantationJ A Hansen, R A Clift, E D Thomas, et al.
Annual Review of Medicine|January 1, 1974
Marrow transplantation for aplastic anemia and acute leukemiaP Neiman, E D Thomas, C D Buckner, et al.
Transplantation Proceedings|December 1, 1987
Comparison of techniques for dealing with major ABO-incompatible marrow transplantsW I Bensinger, C D Buckner, R A Clift, et al.
Cancer|July 15, 1994
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed diseaseT Demirer, C D Buckner, K Lilleby, et al.
Progress in Clinical and Biological Research|January 1, 1987
Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantationA Fefer, K M Sullivan, P Weiden, et al.
The New England Journal of Medicine|May 10, 1979
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graftsP L Weiden, N Flournoy, E D Thomas, et al.
Pageof 42

Showing results (111-120 of 417) with videos related to

Sort By:
Pageof 42
Cancer Research|October 15, 1989
Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignanciesC M Higuchi, J A Thompson, T Cox, et al.
Archives of Internal Medicine|August 1, 1973
Isogeneic marrow grafts for hematologic malignancy in manR H Rudolph, A Fefer, E D Thomas, et al.
Stem Cells (Dayton, Ohio)|December 1, 1995
Transplantation of allogeneic peripheral blood stem cellsW I Bensinger, F A Appelbaum, T Demirer, et al.
Experimental Hematology|January 1, 1974
Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrowC D Buckner, R A Clift, A Fefer, et al.
Transplantation Proceedings|December 1, 1979
Histocompatibility and marrow transplantationJ A Hansen, R A Clift, E D Thomas, et al.
Annual Review of Medicine|January 1, 1974
Marrow transplantation for aplastic anemia and acute leukemiaP Neiman, E D Thomas, C D Buckner, et al.
Transplantation Proceedings|December 1, 1987
Comparison of techniques for dealing with major ABO-incompatible marrow transplantsW I Bensinger, C D Buckner, R A Clift, et al.
Cancer|July 15, 1994
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed diseaseT Demirer, C D Buckner, K Lilleby, et al.
Progress in Clinical and Biological Research|January 1, 1987
Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantationA Fefer, K M Sullivan, P Weiden, et al.
The New England Journal of Medicine|May 10, 1979
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graftsP L Weiden, N Flournoy, E D Thomas, et al.
Pageof 42